Pages that link to "Q26773795"

The following pages link to Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors (Q26773795):

Displaying 25 items.

• Targeting Angiogenesis in Biliary Tract Cancers: An Open Option (Q30398807) (← links)
• Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor (Q36125976) (← links)
• MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis (Q37144069) (← links)
• Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma (Q37396473) (← links)
• Danshensu, a major water-soluble component of Salvia miltiorrhiza, enhances the radioresponse for Lewis Lung Carcinoma xenografts in mice (Q37701165) (← links)
• Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment. (Q37735605) (← links)
• Structural and functional identification of vasculogenic mimicry in vitro (Q38648314) (← links)
• Tumor cell vascular mimicry: Novel targeting opportunity in melanoma (Q38710798) (← links)
• Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. (Q41437410) (← links)
• HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma (Q41472694) (← links)
• Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold. (Q42370939) (← links)
• Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy. (Q47099537) (← links)
• Precision Oncology: The Road Ahead. (Q50195535) (← links)
• Non-angiogenic tumours and their influence on cancer biology. (Q52665696) (← links)
• Exosome-Mediated Signaling in Epithelial to Mesenchymal Transition and Tumor Progression (Q61812643) (← links)
• The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration (Q64288274) (← links)
• Targeting angiogenesis in gastrointestinal tumors: current challenges (Q89953634) (← links)
• Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptides (Q89985520) (← links)
• Resistance Mechanisms to Anti-angiogenic Therapies in Cancer (Q90347558) (← links)
• Customizable biomaterials as tools for advanced anti-angiogenic drug discovery (Q90752446) (← links)
• An update on angiogenesis targeting in head and neck squamous cell carcinoma (Q91842338) (← links)
• A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b (Q92465156) (← links)
• Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway (Q92584009) (← links)
• Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer (Q92683670) (← links)
• Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms (Q92734088) (← links)